Measles and Rubella (MR) Vaccine Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Measles and Rubella (MR) Vaccine in global, including the following market information:
Global Measles and Rubella (MR) Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Measles and Rubella (MR) Vaccine Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Measles and Rubella (MR) Vaccine companies in 2021 (%)
The global Measles and Rubella (MR) Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
MR Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Measles and Rubella (MR) Vaccine include PT Bio Farma, Bio-Manguinhos, BE Vaccines and Crucell Switzerland AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Measles and Rubella (MR) Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Measles and Rubella (MR) Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Measles and Rubella (MR) Vaccine Market Segment Percentages, by Type, 2021 (%)
Global Measles and Rubella (MR) Vaccine Market Segment Percentages, by Application, 2021 (%)
Global Measles and Rubella (MR) Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Measles and Rubella (MR) Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Measles and Rubella (MR) Vaccine revenues share in global market, 2021 (%)
Key companies Measles and Rubella (MR) Vaccine sales in global market, 2017-2022 (Estimated), (Units)
Key companies Measles and Rubella (MR) Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Measles and Rubella (MR) Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Measles and Rubella (MR) Vaccine Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Measles and Rubella (MR) Vaccine companies in 2021 (%)
The global Measles and Rubella (MR) Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
MR Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Measles and Rubella (MR) Vaccine include PT Bio Farma, Bio-Manguinhos, BE Vaccines and Crucell Switzerland AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Measles and Rubella (MR) Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Measles and Rubella (MR) Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Measles and Rubella (MR) Vaccine Market Segment Percentages, by Type, 2021 (%)
- MR Vaccine
- MRBEV Vaccine
Global Measles and Rubella (MR) Vaccine Market Segment Percentages, by Application, 2021 (%)
- Private Distribution Channel
- Public Distribution Channel
Global Measles and Rubella (MR) Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Measles and Rubella (MR) Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Measles and Rubella (MR) Vaccine revenues share in global market, 2021 (%)
Key companies Measles and Rubella (MR) Vaccine sales in global market, 2017-2022 (Estimated), (Units)
Key companies Measles and Rubella (MR) Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- PT Bio Farma
- Bio-Manguinhos
- BE Vaccines
- Crucell Switzerland AG
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Measles and Rubella (MR) Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Measles and Rubella (MR) Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL MEASLES AND RUBELLA (MR) VACCINE OVERALL MARKET SIZE
2.1 Global Measles and Rubella (MR) Vaccine Market Size: 2021 VS 2028
2.2 Global Measles and Rubella (MR) Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Measles and Rubella (MR) Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Measles and Rubella (MR) Vaccine Players in Global Market
3.2 Top Global Measles and Rubella (MR) Vaccine Companies Ranked by Revenue
3.3 Global Measles and Rubella (MR) Vaccine Revenue by Companies
3.4 Global Measles and Rubella (MR) Vaccine Sales by Companies
3.5 Global Measles and Rubella (MR) Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Measles and Rubella (MR) Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Measles and Rubella (MR) Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Measles and Rubella (MR) Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Measles and Rubella (MR) Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Measles and Rubella (MR) Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Measles and Rubella (MR) Vaccine Market Size Markets, 2021 & 2028
4.1.2 MR Vaccine
4.1.3 MRBEV Vaccine
4.2 By Type - Global Measles and Rubella (MR) Vaccine Revenue & Forecasts
4.2.1 By Type - Global Measles and Rubella (MR) Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Measles and Rubella (MR) Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Measles and Rubella (MR) Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Measles and Rubella (MR) Vaccine Sales & Forecasts
4.3.1 By Type - Global Measles and Rubella (MR) Vaccine Sales, 2017-2022
4.3.2 By Type - Global Measles and Rubella (MR) Vaccine Sales, 2023-2028
4.3.3 By Type - Global Measles and Rubella (MR) Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Measles and Rubella (MR) Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Measles and Rubella (MR) Vaccine Market Size, 2021 & 2028
5.1.2 Private Distribution Channel
5.1.3 Public Distribution Channel
5.2 By Application - Global Measles and Rubella (MR) Vaccine Revenue & Forecasts
5.2.1 By Application - Global Measles and Rubella (MR) Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Measles and Rubella (MR) Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Measles and Rubella (MR) Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Measles and Rubella (MR) Vaccine Sales & Forecasts
5.3.1 By Application - Global Measles and Rubella (MR) Vaccine Sales, 2017-2022
5.3.2 By Application - Global Measles and Rubella (MR) Vaccine Sales, 2023-2028
5.3.3 By Application - Global Measles and Rubella (MR) Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Measles and Rubella (MR) Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Measles and Rubella (MR) Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Measles and Rubella (MR) Vaccine Revenue & Forecasts
6.2.1 By Region - Global Measles and Rubella (MR) Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Measles and Rubella (MR) Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Measles and Rubella (MR) Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Measles and Rubella (MR) Vaccine Sales & Forecasts
6.3.1 By Region - Global Measles and Rubella (MR) Vaccine Sales, 2017-2022
6.3.2 By Region - Global Measles and Rubella (MR) Vaccine Sales, 2023-2028
6.3.3 By Region - Global Measles and Rubella (MR) Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Measles and Rubella (MR) Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Measles and Rubella (MR) Vaccine Sales, 2017-2028
6.4.3 US Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.4.4 Canada Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.4.5 Mexico Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Measles and Rubella (MR) Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Measles and Rubella (MR) Vaccine Sales, 2017-2028
6.5.3 Germany Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.5.4 France Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.5.5 U.K. Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.5.6 Italy Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.5.7 Russia Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.5.9 Benelux Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Measles and Rubella (MR) Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Measles and Rubella (MR) Vaccine Sales, 2017-2028
6.6.3 China Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.6.4 Japan Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.6.5 South Korea Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.6.7 India Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Measles and Rubella (MR) Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Measles and Rubella (MR) Vaccine Sales, 2017-2028
6.7.3 Brazil Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.7.4 Argentina Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Measles and Rubella (MR) Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Measles and Rubella (MR) Vaccine Sales, 2017-2028
6.8.3 Turkey Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.8.4 Israel Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.8.6 UAE Measles and Rubella (MR) Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 PT Bio Farma
7.1.1 PT Bio Farma Corporate Summary
7.1.2 PT Bio Farma Business Overview
7.1.3 PT Bio Farma Measles and Rubella (MR) Vaccine Major Product Offerings
7.1.4 PT Bio Farma Measles and Rubella (MR) Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 PT Bio Farma Key News
7.2 Bio-Manguinhos
7.2.1 Bio-Manguinhos Corporate Summary
7.2.2 Bio-Manguinhos Business Overview
7.2.3 Bio-Manguinhos Measles and Rubella (MR) Vaccine Major Product Offerings
7.2.4 Bio-Manguinhos Measles and Rubella (MR) Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Bio-Manguinhos Key News
7.3 BE Vaccines
7.3.1 BE Vaccines Corporate Summary
7.3.2 BE Vaccines Business Overview
7.3.3 BE Vaccines Measles and Rubella (MR) Vaccine Major Product Offerings
7.3.4 BE Vaccines Measles and Rubella (MR) Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 BE Vaccines Key News
7.4 Crucell Switzerland AG
7.4.1 Crucell Switzerland AG Corporate Summary
7.4.2 Crucell Switzerland AG Business Overview
7.4.3 Crucell Switzerland AG Measles and Rubella (MR) Vaccine Major Product Offerings
7.4.4 Crucell Switzerland AG Measles and Rubella (MR) Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Crucell Switzerland AG Key News
8 GLOBAL MEASLES AND RUBELLA (MR) VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Measles and Rubella (MR) Vaccine Production Capacity, 2017-2028
8.2 Measles and Rubella (MR) Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Measles and Rubella (MR) Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 MEASLES AND RUBELLA (MR) VACCINE SUPPLY CHAIN ANALYSIS
10.1 Measles and Rubella (MR) Vaccine Industry Value Chain
10.2 Measles and Rubella (MR) Vaccine Upstream Market
10.3 Measles and Rubella (MR) Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Measles and Rubella (MR) Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Measles and Rubella (MR) Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Measles and Rubella (MR) Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL MEASLES AND RUBELLA (MR) VACCINE OVERALL MARKET SIZE
2.1 Global Measles and Rubella (MR) Vaccine Market Size: 2021 VS 2028
2.2 Global Measles and Rubella (MR) Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Measles and Rubella (MR) Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Measles and Rubella (MR) Vaccine Players in Global Market
3.2 Top Global Measles and Rubella (MR) Vaccine Companies Ranked by Revenue
3.3 Global Measles and Rubella (MR) Vaccine Revenue by Companies
3.4 Global Measles and Rubella (MR) Vaccine Sales by Companies
3.5 Global Measles and Rubella (MR) Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Measles and Rubella (MR) Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Measles and Rubella (MR) Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Measles and Rubella (MR) Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Measles and Rubella (MR) Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Measles and Rubella (MR) Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Measles and Rubella (MR) Vaccine Market Size Markets, 2021 & 2028
4.1.2 MR Vaccine
4.1.3 MRBEV Vaccine
4.2 By Type - Global Measles and Rubella (MR) Vaccine Revenue & Forecasts
4.2.1 By Type - Global Measles and Rubella (MR) Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Measles and Rubella (MR) Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Measles and Rubella (MR) Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Measles and Rubella (MR) Vaccine Sales & Forecasts
4.3.1 By Type - Global Measles and Rubella (MR) Vaccine Sales, 2017-2022
4.3.2 By Type - Global Measles and Rubella (MR) Vaccine Sales, 2023-2028
4.3.3 By Type - Global Measles and Rubella (MR) Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Measles and Rubella (MR) Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Measles and Rubella (MR) Vaccine Market Size, 2021 & 2028
5.1.2 Private Distribution Channel
5.1.3 Public Distribution Channel
5.2 By Application - Global Measles and Rubella (MR) Vaccine Revenue & Forecasts
5.2.1 By Application - Global Measles and Rubella (MR) Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Measles and Rubella (MR) Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Measles and Rubella (MR) Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Measles and Rubella (MR) Vaccine Sales & Forecasts
5.3.1 By Application - Global Measles and Rubella (MR) Vaccine Sales, 2017-2022
5.3.2 By Application - Global Measles and Rubella (MR) Vaccine Sales, 2023-2028
5.3.3 By Application - Global Measles and Rubella (MR) Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Measles and Rubella (MR) Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Measles and Rubella (MR) Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Measles and Rubella (MR) Vaccine Revenue & Forecasts
6.2.1 By Region - Global Measles and Rubella (MR) Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Measles and Rubella (MR) Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Measles and Rubella (MR) Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Measles and Rubella (MR) Vaccine Sales & Forecasts
6.3.1 By Region - Global Measles and Rubella (MR) Vaccine Sales, 2017-2022
6.3.2 By Region - Global Measles and Rubella (MR) Vaccine Sales, 2023-2028
6.3.3 By Region - Global Measles and Rubella (MR) Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Measles and Rubella (MR) Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Measles and Rubella (MR) Vaccine Sales, 2017-2028
6.4.3 US Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.4.4 Canada Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.4.5 Mexico Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Measles and Rubella (MR) Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Measles and Rubella (MR) Vaccine Sales, 2017-2028
6.5.3 Germany Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.5.4 France Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.5.5 U.K. Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.5.6 Italy Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.5.7 Russia Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.5.9 Benelux Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Measles and Rubella (MR) Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Measles and Rubella (MR) Vaccine Sales, 2017-2028
6.6.3 China Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.6.4 Japan Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.6.5 South Korea Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.6.7 India Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Measles and Rubella (MR) Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Measles and Rubella (MR) Vaccine Sales, 2017-2028
6.7.3 Brazil Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.7.4 Argentina Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Measles and Rubella (MR) Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Measles and Rubella (MR) Vaccine Sales, 2017-2028
6.8.3 Turkey Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.8.4 Israel Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Measles and Rubella (MR) Vaccine Market Size, 2017-2028
6.8.6 UAE Measles and Rubella (MR) Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 PT Bio Farma
7.1.1 PT Bio Farma Corporate Summary
7.1.2 PT Bio Farma Business Overview
7.1.3 PT Bio Farma Measles and Rubella (MR) Vaccine Major Product Offerings
7.1.4 PT Bio Farma Measles and Rubella (MR) Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 PT Bio Farma Key News
7.2 Bio-Manguinhos
7.2.1 Bio-Manguinhos Corporate Summary
7.2.2 Bio-Manguinhos Business Overview
7.2.3 Bio-Manguinhos Measles and Rubella (MR) Vaccine Major Product Offerings
7.2.4 Bio-Manguinhos Measles and Rubella (MR) Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Bio-Manguinhos Key News
7.3 BE Vaccines
7.3.1 BE Vaccines Corporate Summary
7.3.2 BE Vaccines Business Overview
7.3.3 BE Vaccines Measles and Rubella (MR) Vaccine Major Product Offerings
7.3.4 BE Vaccines Measles and Rubella (MR) Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 BE Vaccines Key News
7.4 Crucell Switzerland AG
7.4.1 Crucell Switzerland AG Corporate Summary
7.4.2 Crucell Switzerland AG Business Overview
7.4.3 Crucell Switzerland AG Measles and Rubella (MR) Vaccine Major Product Offerings
7.4.4 Crucell Switzerland AG Measles and Rubella (MR) Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Crucell Switzerland AG Key News
8 GLOBAL MEASLES AND RUBELLA (MR) VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Measles and Rubella (MR) Vaccine Production Capacity, 2017-2028
8.2 Measles and Rubella (MR) Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Measles and Rubella (MR) Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 MEASLES AND RUBELLA (MR) VACCINE SUPPLY CHAIN ANALYSIS
10.1 Measles and Rubella (MR) Vaccine Industry Value Chain
10.2 Measles and Rubella (MR) Vaccine Upstream Market
10.3 Measles and Rubella (MR) Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Measles and Rubella (MR) Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Measles and Rubella (MR) Vaccine in Global Market
Table 2. Top Measles and Rubella (MR) Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Measles and Rubella (MR) Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Measles and Rubella (MR) Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Measles and Rubella (MR) Vaccine Sales by Companies, (Units), 2017-2022
Table 6. Global Measles and Rubella (MR) Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Measles and Rubella (MR) Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Measles and Rubella (MR) Vaccine Product Type
Table 9. List of Global Tier 1 Measles and Rubella (MR) Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Measles and Rubella (MR) Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Measles and Rubella (MR) Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Measles and Rubella (MR) Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Measles and Rubella (MR) Vaccine Sales (Units), 2017-2022
Table 15. By Type - Global Measles and Rubella (MR) Vaccine Sales (Units), 2023-2028
Table 16. By Application – Global Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Measles and Rubella (MR) Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Measles and Rubella (MR) Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Measles and Rubella (MR) Vaccine Sales (Units), 2017-2022
Table 20. By Application - Global Measles and Rubella (MR) Vaccine Sales (Units), 2023-2028
Table 21. By Region – Global Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Measles and Rubella (MR) Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Measles and Rubella (MR) Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Measles and Rubella (MR) Vaccine Sales (Units), 2017-2022
Table 25. By Region - Global Measles and Rubella (MR) Vaccine Sales (Units), 2023-2028
Table 26. By Country - North America Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Measles and Rubella (MR) Vaccine Sales, (Units), 2017-2022
Table 29. By Country - North America Measles and Rubella (MR) Vaccine Sales, (Units), 2023-2028
Table 30. By Country - Europe Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Measles and Rubella (MR) Vaccine Sales, (Units), 2017-2022
Table 33. By Country - Europe Measles and Rubella (MR) Vaccine Sales, (Units), 2023-2028
Table 34. By Region - Asia Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Measles and Rubella (MR) Vaccine Sales, (Units), 2017-2022
Table 37. By Region - Asia Measles and Rubella (MR) Vaccine Sales, (Units), 2023-2028
Table 38. By Country - South America Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Measles and Rubella (MR) Vaccine Sales, (Units), 2017-2022
Table 41. By Country - South America Measles and Rubella (MR) Vaccine Sales, (Units), 2023-2028
Table 42. By Country - Middle East & Africa Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Measles and Rubella (MR) Vaccine Sales, (Units), 2017-2022
Table 45. By Country - Middle East & Africa Measles and Rubella (MR) Vaccine Sales, (Units), 2023-2028
Table 46. PT Bio Farma Corporate Summary
Table 47. PT Bio Farma Measles and Rubella (MR) Vaccine Product Offerings
Table 48. PT Bio Farma Measles and Rubella (MR) Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Bio-Manguinhos Corporate Summary
Table 50. Bio-Manguinhos Measles and Rubella (MR) Vaccine Product Offerings
Table 51. Bio-Manguinhos Measles and Rubella (MR) Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. BE Vaccines Corporate Summary
Table 53. BE Vaccines Measles and Rubella (MR) Vaccine Product Offerings
Table 54. BE Vaccines Measles and Rubella (MR) Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Crucell Switzerland AG Corporate Summary
Table 56. Crucell Switzerland AG Measles and Rubella (MR) Vaccine Product Offerings
Table 57. Crucell Switzerland AG Measles and Rubella (MR) Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Measles and Rubella (MR) Vaccine Production Capacity (Units) of Key Manufacturers in Global Market, 2020-2022 (Units)
Table 59. Global Measles and Rubella (MR) Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 60. Global Measles and Rubella (MR) Vaccine Production by Region, 2017-2022 (Units)
Table 61. Global Measles and Rubella (MR) Vaccine Production by Region, 2023-2028 (Units)
Table 62. Measles and Rubella (MR) Vaccine Market Opportunities & Trends in Global Market
Table 63. Measles and Rubella (MR) Vaccine Market Drivers in Global Market
Table 64. Measles and Rubella (MR) Vaccine Market Restraints in Global Market
Table 65. Measles and Rubella (MR) Vaccine Raw Materials
Table 66. Measles and Rubella (MR) Vaccine Raw Materials Suppliers in Global Market
Table 67. Typical Measles and Rubella (MR) Vaccine Downstream
Table 68. Measles and Rubella (MR) Vaccine Downstream Clients in Global Market
Table 69. Measles and Rubella (MR) Vaccine Distributors and Sales Agents in Global Market
Table 1. Key Players of Measles and Rubella (MR) Vaccine in Global Market
Table 2. Top Measles and Rubella (MR) Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Measles and Rubella (MR) Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Measles and Rubella (MR) Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Measles and Rubella (MR) Vaccine Sales by Companies, (Units), 2017-2022
Table 6. Global Measles and Rubella (MR) Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Measles and Rubella (MR) Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Measles and Rubella (MR) Vaccine Product Type
Table 9. List of Global Tier 1 Measles and Rubella (MR) Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Measles and Rubella (MR) Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Measles and Rubella (MR) Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Measles and Rubella (MR) Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Measles and Rubella (MR) Vaccine Sales (Units), 2017-2022
Table 15. By Type - Global Measles and Rubella (MR) Vaccine Sales (Units), 2023-2028
Table 16. By Application – Global Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Measles and Rubella (MR) Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Measles and Rubella (MR) Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Measles and Rubella (MR) Vaccine Sales (Units), 2017-2022
Table 20. By Application - Global Measles and Rubella (MR) Vaccine Sales (Units), 2023-2028
Table 21. By Region – Global Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Measles and Rubella (MR) Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Measles and Rubella (MR) Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Measles and Rubella (MR) Vaccine Sales (Units), 2017-2022
Table 25. By Region - Global Measles and Rubella (MR) Vaccine Sales (Units), 2023-2028
Table 26. By Country - North America Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Measles and Rubella (MR) Vaccine Sales, (Units), 2017-2022
Table 29. By Country - North America Measles and Rubella (MR) Vaccine Sales, (Units), 2023-2028
Table 30. By Country - Europe Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Measles and Rubella (MR) Vaccine Sales, (Units), 2017-2022
Table 33. By Country - Europe Measles and Rubella (MR) Vaccine Sales, (Units), 2023-2028
Table 34. By Region - Asia Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Measles and Rubella (MR) Vaccine Sales, (Units), 2017-2022
Table 37. By Region - Asia Measles and Rubella (MR) Vaccine Sales, (Units), 2023-2028
Table 38. By Country - South America Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Measles and Rubella (MR) Vaccine Sales, (Units), 2017-2022
Table 41. By Country - South America Measles and Rubella (MR) Vaccine Sales, (Units), 2023-2028
Table 42. By Country - Middle East & Africa Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Measles and Rubella (MR) Vaccine Sales, (Units), 2017-2022
Table 45. By Country - Middle East & Africa Measles and Rubella (MR) Vaccine Sales, (Units), 2023-2028
Table 46. PT Bio Farma Corporate Summary
Table 47. PT Bio Farma Measles and Rubella (MR) Vaccine Product Offerings
Table 48. PT Bio Farma Measles and Rubella (MR) Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Bio-Manguinhos Corporate Summary
Table 50. Bio-Manguinhos Measles and Rubella (MR) Vaccine Product Offerings
Table 51. Bio-Manguinhos Measles and Rubella (MR) Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. BE Vaccines Corporate Summary
Table 53. BE Vaccines Measles and Rubella (MR) Vaccine Product Offerings
Table 54. BE Vaccines Measles and Rubella (MR) Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Crucell Switzerland AG Corporate Summary
Table 56. Crucell Switzerland AG Measles and Rubella (MR) Vaccine Product Offerings
Table 57. Crucell Switzerland AG Measles and Rubella (MR) Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Measles and Rubella (MR) Vaccine Production Capacity (Units) of Key Manufacturers in Global Market, 2020-2022 (Units)
Table 59. Global Measles and Rubella (MR) Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 60. Global Measles and Rubella (MR) Vaccine Production by Region, 2017-2022 (Units)
Table 61. Global Measles and Rubella (MR) Vaccine Production by Region, 2023-2028 (Units)
Table 62. Measles and Rubella (MR) Vaccine Market Opportunities & Trends in Global Market
Table 63. Measles and Rubella (MR) Vaccine Market Drivers in Global Market
Table 64. Measles and Rubella (MR) Vaccine Market Restraints in Global Market
Table 65. Measles and Rubella (MR) Vaccine Raw Materials
Table 66. Measles and Rubella (MR) Vaccine Raw Materials Suppliers in Global Market
Table 67. Typical Measles and Rubella (MR) Vaccine Downstream
Table 68. Measles and Rubella (MR) Vaccine Downstream Clients in Global Market
Table 69. Measles and Rubella (MR) Vaccine Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Measles and Rubella (MR) Vaccine Segment by Type
Figure 2. Measles and Rubella (MR) Vaccine Segment by Application
Figure 3. Global Measles and Rubella (MR) Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Measles and Rubella (MR) Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Measles and Rubella (MR) Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Measles and Rubella (MR) Vaccine Sales in Global Market: 2017-2028 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Measles and Rubella (MR) Vaccine Revenue in 2021
Figure 9. By Type - Global Measles and Rubella (MR) Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Measles and Rubella (MR) Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Measles and Rubella (MR) Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Measles and Rubella (MR) Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Measles and Rubella (MR) Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Measles and Rubella (MR) Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Measles and Rubella (MR) Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Measles and Rubella (MR) Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Measles and Rubella (MR) Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Measles and Rubella (MR) Vaccine Sales Market Share, 2017-2028
Figure 19. US Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Measles and Rubella (MR) Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Measles and Rubella (MR) Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Measles and Rubella (MR) Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Measles and Rubella (MR) Vaccine Sales Market Share, 2017-2028
Figure 33. China Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Measles and Rubella (MR) Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Measles and Rubella (MR) Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Measles and Rubella (MR) Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Measles and Rubella (MR) Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Measles and Rubella (MR) Vaccine Production Capacity (Units), 2017-2028
Figure 49. The Percentage of Production Measles and Rubella (MR) Vaccine by Region, 2021 VS 2028
Figure 50. Measles and Rubella (MR) Vaccine Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Measles and Rubella (MR) Vaccine Segment by Type
Figure 2. Measles and Rubella (MR) Vaccine Segment by Application
Figure 3. Global Measles and Rubella (MR) Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Measles and Rubella (MR) Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Measles and Rubella (MR) Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Measles and Rubella (MR) Vaccine Sales in Global Market: 2017-2028 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Measles and Rubella (MR) Vaccine Revenue in 2021
Figure 9. By Type - Global Measles and Rubella (MR) Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Measles and Rubella (MR) Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Measles and Rubella (MR) Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Measles and Rubella (MR) Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Measles and Rubella (MR) Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Measles and Rubella (MR) Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Measles and Rubella (MR) Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Measles and Rubella (MR) Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Measles and Rubella (MR) Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Measles and Rubella (MR) Vaccine Sales Market Share, 2017-2028
Figure 19. US Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Measles and Rubella (MR) Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Measles and Rubella (MR) Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Measles and Rubella (MR) Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Measles and Rubella (MR) Vaccine Sales Market Share, 2017-2028
Figure 33. China Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Measles and Rubella (MR) Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Measles and Rubella (MR) Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Measles and Rubella (MR) Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Measles and Rubella (MR) Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Measles and Rubella (MR) Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Measles and Rubella (MR) Vaccine Production Capacity (Units), 2017-2028
Figure 49. The Percentage of Production Measles and Rubella (MR) Vaccine by Region, 2021 VS 2028
Figure 50. Measles and Rubella (MR) Vaccine Industry Value Chain
Figure 51. Marketing Channels
